Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and lymphoma. Skeletal formula. Stock Illustration | Adobe Stock
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
Principles of Chemotherapy and Chemotherapy Complications zlem Snmez
Palmar–Plantar Rash with Cytarabine Therapy | NEJM
Cytarabine (cytosine arabinoside, ara-c) chemotherapy drug molecule. used in treatment of acute myeloid leukemia (aml), acute | CanStock
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells - ScienceDirect
Cytarabine Cytosine Arabinoside Arac Chemotherapy Drug Stock Vector (Royalty Free) 791676376 | Shutterstock
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Cytarabine, (cytosine, arabinoside, ara-c), chemotherapy, 藥物, molec 攝影圖庫| k19114995 | Fotosearch
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug molecule. Used in treatment of acute myeloid leukemia (AML), etc Stock Photo - Alamy
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review | HTML
Cytarabine (cytosine Arabinoside, Ara-C) Chemotherapy Drug Molecule. Used in Treatment of Acute Myeloid Leukemia (AML), Acute Stock Illustration - Illustration of lymphocytic, lymphoma: 188460947
Cytarabine (cytosine arabinoside, Ara-C) chemotherapy drug. Stock Illustration | Adobe Stock
Vector Art - Cytarabine (cytosine arabinoside, ara-c) chemotherapy drug molecule. used in treatment of acute myeloid leukemia (aml), acute lymphocytic leukemia (all) and lymphoma. Clipart Drawing gg75682591 - GoGraph
Chemotherapy dosing schedule. The schedule for ARA-C (200 mg/m 2 /d),... | Download Scientific Diagram
Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells - Journal of Lipid Research
Frontiers | ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
Cytarabine chemotherapy, uses, dose & cytarabine side effects
Cytarabine (cytosine arabinoside, ara-c) chemotherapy drug molecule. used in treatment of acute myeloid leukemia (aml), acute | CanStock
Cytarabine Injection, for Clinical, Vial, Rs 900/piece Million Health Pharmaceuticals | ID: 9183727197
Cytarabine - Wikipedia
Cytarabine Cytosine Arabinoside, Ara-C Chemotherapy Drug Molecule. Used in Treatment of Acute Myeloid Leukemia AML, Acute. Stock Illustration - Illustration of model, lymphoma: 187975189
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase η | Scientific Reports
